Unimed Biotech Co.
Latest round
- Series A
Last raised
- Dec 2019
Total raised
- Undisclosed
Investors
- 1
About Unimed Biotech Co.
Based in Shanghai, China and established in 2013, Unimed Biotech Co. Ltd. is a biotechnology company that focuses on reproduction and genetics technology providing pre-pregnancy genetic testing and testing equipment. The company was founded by Shen Yang, who holds a Master's degree in Public Health Management from Yale University and has nearly 20 years of experience in the field of assisted reproduction. Shen has worked with domestic prenatal diagnosis centers and reproductive centers to build technical platforms. The core team of Unimed Biotech consists of top researchers, engineers, and operational staff from around the world, with 19 doctors and 20 masters among its members. The company has developed innovative technologies in the capture and separation of rare cells, chip technology, sequencing, and bioinformatics analysis. Unimed Biotech offers a range of services and products in the reproductive and genetic sectors. The company's key offerings include pre-implantation genetic testing (PGT), prenatal screening, prenatal diagnosis, and its proprietary single-cell non-invasive prenatal gene testing technology known as cb-NIPT. The cb-NIPT technology allows for the detection of fetal cells in maternal blood for comprehensive genomic information, avoiding the influence of maternal genetic background. The company also provides a complete set of solutions for the challenges encountered in the process of creating a third-generation test-tube baby, including SNP chip platform construction and training for embryo biopsy and PGT chip experiments. The company generates revenue by providing molecular diagnostic tests, genetic diagnosis for hereditary diseases, microbial identification, normal flora testing, and precision treatment for tumor individualization. It also offers professional medical testing and scientific research services.
Who invested in Unimed Biotech Co.
1 investor across 1 round
See all investors in Unimed Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 5, 2019
Amount
Undisclosed
Investors
Questions about Unimed Biotech Co.
Who invested in Unimed Biotech Co.?
Unimed Biotech Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Unimed Biotech Co. raised?
Unimed Biotech Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Unimed Biotech Co. last raise money?
Unimed Biotech Co.'s most recent round on record is a Series A, in Dec 2019.
What does Unimed Biotech Co. do?
Based in Shanghai, China and established in 2013, Unimed Biotech Co.
Where is Unimed Biotech Co. headquartered?
Unimed Biotech Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Unimed Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Unimed Biotech Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Unimed Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.